- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Andaris gets ultrasound contrast patent
Add U.K. firm Andaris to the list of companies with patents on ultrasound contrast technology. The Nottingham firm reported this month that it has received patent No. 5,741,478 from the U.S. Patent and Trademark Office for its microcapsule technology.
Add U.K. firm Andaris to the list of companies with patents on ultrasound contrast technology. The Nottingham firm reported this month that it has received patent No. 5,741,478 from the U.S. Patent and Trademark Office for its microcapsule technology. The patent applies to its Quantison and Myomap ultrasound contrast agents under development, as well as its platelet substitute, Synthocytes, Andaris said.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
